SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Clinuvel Pharmaceuticals Ltd -- Ignore unavailable to you. Want to Upgrade?


To: caly who wrote (3)1/20/2005 9:24:11 PM
From: caly  Read Replies (1) | Respond to of 52
 
Friday 21 January 2005

Dr Wayne Millen retires as CEO of EpiTan

Iain Kirkwood appointed CEO

For more information contact:
Davina Bridgeman, Investor Relations & Marketing, EpiTan Limited, Telephone +61 3 9660 4900
investorrelations@epitan.com.au
Richard Allen, Oxygen Financial Public Relations, Telephone +61 3 9915 6341
Melbourne, Australia

EpiTan Limited (ASX:EPT, ADR:EPTNY, XETRA:UR9) today announced that Dr Wayne Millen is to step down from all executive offices within the company at the end of his five year contract on 31 January 2005. He will remain as a director and non-executive Chairman of the company and will be available to the company as a consultant. EpiTan’s Chief Financial Officer Iain Kirkwood has been appointed as EpiTan’s Chief Executive Officer, to begin on 1 February 2005. He will join the company’s Board on the same date. The Board is confident that Mr Kirkwood’s history with the company as well as his broad commercial experience will lead to a seamless transition in executive management.

Mr Kirkwood joined EpiTan in February 2003 and has brought the company extensive financial and commercial expertise, gained over a 30-year career in Australia, Britain and USA. He has held a range of senior positions with public companies including F.H. Faulding & Co, where he was Chief Financial Officer, Santos Limited and Pilkington Plc.

Link to full release: epitan.com.au